Literature DB >> 26629252

Correlation between high density lipoprotein and monocyte subpopulations among stable coronary atherosclerotic heart disease patients.

Rong-Hai Yang1, Ying-Feng Liu2, Xue-Jun Wang3, Jian-Guang Liang4, Jia-Chao Liu4.   

Abstract

High density lipoprotein (HDL) is a structurally and functionally heterogeneous molecular particle whose function is unclear in atherosclerosis at present. Studies show that small HDL functional imbalance may exist in Coronary Atherosclerotic Heart Disease (CAD) patients. Monocyte is considered to play an important role in atherosclerosis, in accordance with the expression of superficial CD14 and CD16, it can be divided into three subpopulations. The purpose of this study was to explore the relation between HDL and monocyte subpopulations among CAD patients. We report 90 cases of stable CAD patients and define the monocyte subpopulations as classical monocyte (CD14++CD16-; CM), intermediate monocyte (CD14+CD16+; IM), and non-classical monocyte (CD14+CD16++; NCM); HDL group is measured by polyacrylamide gel electrophoresis. The results indicated that the small HDL in blood serum has a correlation with proinflammatory NCM in circulation but a negative correction with CM and no relationship with diabetes, saccharify hemoglobin, hypertension, smoking history and taking dose of statins drugs and severity of disease. In conclusion, this study primarily confirms that micromolecule HDL level correlates with the increase of non-classical monocyte subpopulations and decrease of classical monocyte quantity. Thus demonstrates the proinflammatory correlation between micromolecule HDL and internal immunity in the development of stable atherosclerosis.

Entities:  

Keywords:  High density lipoprotein; atherosclerosis; inflammation; monocyte subpopulations

Year:  2015        PMID: 26629252      PMCID: PMC4659140     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

1.  Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris.

Authors:  Manabu Kashiwagi; Toshio Imanishi; Hiroto Tsujioka; Hideyuki Ikejima; Akio Kuroi; Yuichi Ozaki; Kohei Ishibashi; Kenichi Komukai; Takashi Tanimoto; Yasushi Ino; Hironori Kitabata; Kumiko Hirata; Takashi Akasaka
Journal:  Atherosclerosis       Date:  2010-05-11       Impact factor: 5.162

2.  Monocyte heterogeneity in obesity and subclinical atherosclerosis.

Authors:  Kyrill S Rogacev; Christof Ulrich; Lutz Blömer; Florian Hornof; Katrin Oster; Maren Ziegelin; Bodo Cremers; Yvonne Grenner; Jürgen Geisel; Axel Schlitt; Hans Köhler; Danilo Fliser; Matthias Girndt; Gunnar H Heine
Journal:  Eur Heart J       Date:  2009-08-17       Impact factor: 29.983

3.  The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.

Authors:  Kai-Uwe Belge; Farshid Dayyani; Alexia Horelt; Maciej Siedlar; Marion Frankenberger; Bernhard Frankenberger; Terje Espevik; Löms Ziegler-Heitbrock
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 4.  High-density lipoprotein subfractions--what the clinicians need to know.

Authors:  Angela Pirillo; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Cardiology       Date:  2013-02-20       Impact factor: 1.869

5.  Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.

Authors:  E Nobécourt; S Jacqueminet; B Hansel; S Chantepie; A Grimaldi; M J Chapman; A Kontush
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

6.  Cardiovascular disease in Europe: epidemiological update.

Authors:  Melanie Nichols; Nick Townsend; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2013-09-07       Impact factor: 29.983

Review 7.  Monocyte heterogeneity in human cardiovascular disease.

Authors:  Adam M Zawada; Kyrill S Rogacev; Stephan H Schirmer; Martina Sester; Michael Böhm; Danilo Fliser; Gunnar H Heine
Journal:  Immunobiology       Date:  2012-07-25       Impact factor: 3.144

8.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

9.  CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels.

Authors:  Axel Schlitt; Gunnar H Heine; Stefan Blankenberg; Christine Espinola-Klein; Joern F Dopheide; Christoph Bickel; Karl J Lackner; Mete Iz; Juergen Meyer; Harald Darius; Hans J Rupprecht
Journal:  Thromb Haemost       Date:  2004-08       Impact factor: 5.249

10.  Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment.

Authors:  Sigliti-Henrietta Pelidou; Sotirios Giannopoulos; Sotiria Tzavidi; Georgios Lagos; Athanassios P Kyritsis
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

View more
  1 in total

1.  High-Density Lipoprotein Reduction Differentially Modulates to Classical and Nonclassical Monocyte Subpopulations in Metabolic Syndrome Patients and in LPS-Stimulated Primary Human Monocytes In Vitro.

Authors:  Johanna L Grün; Aaron N Manjarrez-Reyna; Angélica Y Gómez-Arauz; Sonia Leon-Cabrera; Felix Rückert; José M Fragoso; Nallely Bueno-Hernández; Sergio Islas-Andrade; Guillermo Meléndez-Mier; Galileo Escobedo
Journal:  J Immunol Res       Date:  2018-04-03       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.